The Online Investor
Diagnostics M&A image Diagnostics M&A » By The Online Investor Staff, updated Fri., Apr. 19, 5:13 AM Recent mergers and acquisitions in the Diagnostics M&A category.

Slide #74. MEDNAX, Inc. Gwinnett Anesthesia Service, P.C.

Acquirer: MEDNAX, Inc. (NYSE:MD)
Acquiree: Gwinnett Anesthesia Service, P.C.
Details: MEDNAX, Inc., (NYSE:MD) today announced the acquisition of Gwinnett Anesthesia Service, P.C., a physician group practice based in Lawrenceville, Georgia. The practice provides anesthesia services at Gwinnett Medical Center in Lawrenceville and Duluth, as well as at surgery centers and other outpatient facilities throughout those metropolitan areas. The practice will become part of MEDNAX's American Anesthesiology division and is the third Georgia-based practice to join the company.

Pediatrix Medical Group is a provider of physician services including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. Co.'s network comprised of physicians, including physicians who provide neonatal clinical care, primarily within hospital-based neonatal intensive care units, to babies born prematurely or with medical complications. Co.'s network also includes other pediatric subspecialists, including physicians providing pediatric intensive care, physicians providing pediatric cardiology care, physicians providing hospital-based pediatric care, physicians providing pediatric surgical care and urology services, and physicians providing pediatric ear.

MD SEC Filing Email Alerts Service


Open the MD Page at The Online Investor »

Company Name: 
Pediatrix Medical Group Inc
Stock buyback: 
MD buyback
Website: 
www.Pediatrix.com
Sector: 
Diagnostics
Number of ETFs Holding MD: 
46
Total Market Value Held by ETFs: 
$185.05M
Total Market Capitalization: 
$750.00M
% of Market Cap. Held by ETFs: 
24.67%
 

Open the MD Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree MD Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (1.87 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)

Analysts' Target Price:
MD Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Diagnostics M&A - Slide 74 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.